Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic
/PRNewswire/ -- Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by...